FollowTheFilings
Managers
Activity
Compare
Newest
Investment
LB PHARMACEUTICALS INC
Historical 13F holders
CUSIP
50180M108
Type
Equity
Class
COM SHS
Period
13F filings
2026 Q1
2
2025 Q4
3
2025 Q3
3